Seizure risk in multiple sclerosis patients treated with disease-modifying therapy: A systematic review and network meta-analysis.

Yew Li DangVivien Ty YongSifat SharminPiero PeruccaTomas Kalincik

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)

No evidence of association was found between disease-modifying therapy and seizure risk-this informs seizure management in multiple sclerosis patients.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
temporal lobe epilepsy
white matter
prognostic factors
peritoneal dialysis
patient reported outcomes
bone marrow
replacement therapy